Alumis ALMS
NASDAQ ALMS
$6.87 +0.17 (+2.54%)
As of: Oct 21, 2026 · 10:30 AM EDT

Alumis (ALMS) Operating Income (2023 - 2026)

Updated

Alumis (ALMS) recorded Operating Income of -$148.86 million in Q2 2026, compared with -$140.54 million a year earlier.

Analysis

Alumis (ALMS) Operating Income (2023 - 2026) Analysis & Trends

On a TTM basis, Alumis' Operating Income came in at -$501.13 million as of Jun 30, 2026; for FY2025, it came in at -$453.8 million.

  • Across earlier years, Operating Income came in at -$300.75 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Operating Income in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.80 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 614.95 Bn 533.47 Bn 17.26 Bn 7.14 Bn
3 AbbVie 505.05 Bn 478.16 Bn 12.70 Bn 6.43 Bn
4 Merck 368.08 Bn 322.46 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 298.32 Bn 262.31 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.58 Bn 235.26 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.05 Bn 191.45 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 190.61 Bn 164.80 Bn 6.22 Bn -10.39 Bn
9 Pfizer 169.86 Bn 116.50 Bn 10.94 Bn 4.27 Bn
10 Alumis 874.74 Mn -800.10 Mn - -148.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.86 Mn
Dec 31, 2025 -96.45 Mn
Sep 30, 2025 -115.29 Mn
Jun 30, 2025 -140.54 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -98.62 Mn
Sep 30, 2024 -98.40 Mn
Jun 30, 2024 -56.14 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -37.62 Mn
API Access

Alumis Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=ALMS&period=max&api_key=YOUR_API_KEY